Related by context. Frequent words. (Click for all words.) 66 refractory chronic lymphocytic 65 pancreatic neuroendocrine tumors 63 sunitinib malate 62 Vandetanib 62 Irinotecan 62 pancreatic NET 61 HER2 positive metastatic breast 61 gastrointestinal stromal tumors 61 HGS ETR2 61 ovarian breast 61 non squamous 60 colorectal carcinoma 60 androgen independent 60 colorectal lung 60 vandetanib 59 gastrointestinal stromal tumors GIST 59 carcinoid tumors 59 Lenalidomide 59 Allovectin 7 ® 59 Capecitabine 59 IMC #B 59 castrate resistant prostate cancer 59 relapsed refractory multiple myeloma 59 multiple myeloma MM 59 KRAS wild 59 Daclizumab 59 axitinib 59 metastatic renal cell carcinoma 59 leukemia CLL 58 pheochromocytoma 58 Trastuzumab 58 extracranial 58 pertuzumab 58 unresectable 58 xenograft models 58 metastatic hormone refractory 58 luteinizing hormone releasing 58 relapsing multiple sclerosis 58 paclitaxel carboplatin 58 Voreloxin 58 refractory multiple myeloma 58 metastatic breast 58 plus gemcitabine 57 mRCC 57 vorinostat 57 poly ADP ribose polymerase 57 recurrent glioblastoma 57 neoadjuvant therapy 57 pancreatic adenocarcinoma 57 Acute Myeloid Leukemia AML 57 Epidermal Growth Factor Receptor 57 cervical breast 57 5FU 57 mCRC patients 57 Myelofibrosis 57 TTR amyloidosis 57 metastatic liver 57 bleomycin 57 TAXUS Express Stent 57 multi kinase inhibitor 57 Factor VIIa 57 DAVANAT 57 bone metastasis 57 Idiopathic Pulmonary Fibrosis 57 clinically localized prostate 57 carboplatin paclitaxel 56 T#I [002] 56 Thiarabine 56 HER2 negative 56 ALN TTR 56 resectable 56 forodesine 56 transitional cell carcinoma 56 targeting CD# 56 Proxinium TM 56 FOLFOX4 56 cell acute lymphoblastic 56 Dasatinib 56 mycophenolate mofetil 56 lymphoma CTCL 56 vismodegib 56 hepatocellular carcinoma HCC 56 NSABP 56 IRESSA 56 carcinoid 56 experimental autoimmune encephalomyelitis 56 oncolytic 56 metastatic kidney 55 Erlotinib 55 FLT3 55 cholangiocarcinoma 55 neoadjuvant 55 zalutumumab 55 Nephrol 55 hepatocellular cancer 55 leukemia ALL 55 neoadjuvant chemotherapy 55 cutaneous melanoma 55 enzastaurin 55 hepatitis C HCV 55 Median progression